Status
Conditions
About
Hungarian CoronaVirus disease-19 Epidemiological Research
Full description
The planned large-scale, cross-sectional, representative population screening can show the prevalence of COVID-19 and the degree of infection and trans-infection in Hungary after more than one month of strict restriction. In addition, it can have an impact on further actions, and we can track the impact of the decisions we make by repeating the screenings.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Loading...
Central trial contact
Annamaria Kosztin, MD,PhD; Béla Merkely, PhD,DSc
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal